Management of Early Breast Cancer in Southeast Netherlands Since 1984 A Population-Based Study

References

• Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy. axillary dissection and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981; 305: 6–11
   PubMed Web of Science ®Google Scholar
• Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985; 312: 665–73
   PubMed Web of Science ®Google Scholar
• Fisher B, Redmond C, Fisher E R, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674–81
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28 896 women. N Engl J Med 1988; 319: 1681–92
   PubMed Web of Science ®Google Scholar
• Cancer incidence in five continents, D M Parkin, C S Muir, S L Whelan, Y T Gao, J Ferlay, J Powell. IARC Scientific Publication No. 120, International Agency for Research on Cancer, Lyon 1992; Vol. VI
   Google Scholar
• UICC TNM classification of malignant tumours, P Hermanek, L H Sobin. Springer-Verlag, Berlin 1987; 94–9
   Google Scholar
• Hooning M J, van Dongen J A, Went G. Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation. Neth J Surg 1991; 43: 102–4
   PubMedGoogle Scholar
• McCarthy M, Bore J. Treatment of breast cancer in two teaching hospitals: a comparison with consensus guidelines. Eur J Cancer 1991; 27: 579–82
   PubMed Web of Science ®Google Scholar
• Voogd A C, Coebergh J WW, Crommelin M A, van der Heijden L H, Kluck H M. Breast-conserving treatment of early breast cancer: survival and recurrence in community hospitals in southeastern Netherlands. Neth J Surg 1991; 43: 105–9
   PubMedGoogle Scholar
• Greenfield S, Blanco D M, Elashoff R M, Ganz P A. Patterns of care related to age of breast cancer patients. JAMA 1987; 257: 2766–70
   PubMed Web of Science ®Google Scholar
• Silliman R A, Guadagnoli E, Weitberg A B, Mor V. Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients. J Gerontol 1989; 44: 46–50
   PubMedGoogle Scholar
• Lazovich D A, White E, Thomas D B, Moe R E. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 1991; 266: 3433–8
   PubMed Web of Science ®Google Scholar
• Satariano E R, Swanson G M, Moll P P. Nonclinical factors associated with surgery received for treatment of early-stage breast cancer. Am J Public Health 1992; 82: 195–8
   PubMed Web of Science ®Google Scholar
• Nicolucci A, Mainini F, Penna A, et al. The influence of patient characteristics on the appropriateness of surgical treatment for breast cancer patients. Ann Oncol 1993; 4: 133–40
   PubMed Web of Science ®Google Scholar
• Bergman L, Kluck H M, van Leeuwen F E, et al. The influence of age on treatment choice and survival of elderly breast cancer patients in South-eastern Netherlands: a population-based study. Eur J Cancer 1992; 28A: 1475–80
   PubMed Web of Science ®Google Scholar
• Mathiesen O, Carl J, Bonderup O, Panduro J. Axillary sampling and the risk of erroneous staging of breast cancer. Acta Oncol 1990; 29: 721–5
   PubMed Web of Science ®Google Scholar
• Axelsson C K, Mouridsen H T, Zedeler K. on behalf of the Danish Breast Cancer Cooperative Group (DBCG). Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer 1992; 28A: 1415–8
   PubMed Web of Science ®Google Scholar
• Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer: analysis at six years of Nolvadex Adjuvant Trial Organisation. Lancet 1985; 1: 836–40
   PubMed Web of Science ®Google Scholar
• Adjuvant tamoxifen in the management of operable breast cancer. the Scottish Trial: report from the Breast Cancer Trials Committee. Scottish Cancer Trial Office (MRC). Lancet, Edinburgh 1987; 2: 171–5
   Google Scholar